Curiosity Weekly
Psychosis Blood Test, Altitude Genes, PCOS Cognition
Mar 14, 2024
A new blood test predicts psychosis risk for precise treatment, gene mutations allow different populations to thrive at extreme altitudes, and polycystic ovary syndrome is linked to cognitive decline in midlife.
10:05
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- A new blood test can accurately predict psychosis risk and guide precise treatment, revolutionizing early diagnosis of schizophrenia.
- Genetic mutations in the EPA S1 gene enable high-altitude populations to thrive by efficiently utilizing oxygen, offering insights into altitude sickness treatments.
Deep dives
Breakthrough Blood Test for Schizophrenia Diagnosis
A breakthrough blood test has been developed by researchers at Indiana University School of Medicine, allowing accurate diagnosis of schizophrenia by detecting specific biomarkers. Schizophrenia is notoriously difficult to diagnose early due to symptoms like hallucinations and delusions, impacting over 3 million Americans. The new test, detailed in Molecular Psychiatry, predicts psychotic behaviors using blood samples, guiding precision treatments and potentially uncovering biological mechanisms behind the disorder.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
